Vital Signs - The Analyst's Perspective - February 2015 Issue
The president’s fiscal year (FY) 2016 budget request to Congress released in early Feburary proposes an estimated$145.3 billion in total R&D funding (i.e., defense and non-defense), roughly a 6.4% increase in R&D spending fromFY 2015 without factoring in inflation, according to the American Association for the Advancement of Science(AAAS). For scientific research funding, the National Institutes of Health (NIH), National Science Foundation(NSF), Department of Energy’s (DOE) Office of Science, and U.S. Department of Agriculture’s (USDA) Agricultureand Food Research Initiative will all receive increases above the estimated inflation level of 1.6%. Under the budget,NIH would receive $31.3 billion, a $1 billion increase over FY 2015 levels providing a slim, but positive increaseabove inflation levels. The NSF’s budget would increase 5.2% to $7.7 billion. The DOE’s Office of Science wouldincrease 5.4%, with the real winner the Office of Energy with a 28.7% increase directed mostly at the EnergyEfficiency and Renewable Energy, and Electricity Delivery and Energy Reliability programs. USDA’s Agricultureand Food Research Initiative, a peer-reviewed competitive research program, would increase a hefty 40%. Below,AAAS illustrates the FY 2016 budget winners and losers in R&D funding, adjusted for 1.6% inflation.
About this report
This issue of Vital Signs, released on March 2, 2015, discusses the US President's science budget, Pfizer's acquisition of Hospira, China's redefined Foreign Investment Law, and President Obama's Precision Medicine Initiative.
Electronic Access - Site License Fulfilled By Publisher
Electronic Access - Global site License Fulfilled By Publisher